After heart disease, cancer is the most common cause of death in the US.
Death rates from cancer in the US have fallen by 32% over the three decades from 1991 to 2019, according to the American Cancer Society.
In 1991, the cancer death rate was 215 per 100,000 people and in 2019 it dropped to 146 per 100,000 people.But people are being diagnosed sooner, and technological advancements have increased the survival rate by three years. Though having fewer children or having them later has been linked to increasing breast cancer chances, the link is not well understood.The research found that "at least 42% of the projected new cancers are potentially avoidable", noting that 19% of cancers are caused by smoking and 18% of cancers are "caused by a combination of excess body weight, drinking alcohol, poor nutrition, and physical inactivity".
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Charlie Javice Joins List of Forbes '30 Under 30' Alumni Who’ve (Allegedly) Committed FraudJP Morgan, which acquired student aid company Frank, says Javice created millions of fake users to bolster her company's value.
Weiterlesen »
U.S. Cancer Death Rate Has Dropped By a Third Since 1991Breaking: The cancer death rate in America has dropped by a third since 1991, a new report found. But a rise in advanced prostate cancer diagnoses has doctors on alert.
Weiterlesen »
Cancer Death Rates Dropped a Whopping 33% Since 1991Finally, some good news: Overall cancer death rates have declined a massive 33 percent since 1991, according to statistics released by the American Cancer Society.
Weiterlesen »
Cancer Rates Dropped a Whopping 33% Since 1991Finally, some good news: Overall cancer rates have declined a massive 33 percent since 1991, according to statistics released by the American Cancer Society on Jan. 12.
Weiterlesen »
'Hidden gem' in stocks could outperform the market by 30%, says GMOA 'hidden gem' in stocks is poised to outperform the rest of the market by 30%, says Jeremy Grantham's GMO
Weiterlesen »